Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01111721 · ClinicalTrials.gov registry record · NA

Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
598
Enrollment target

NCT01111721: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT01111721 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 598 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01111721, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
598 participants
Enrollment target

Study Summary

Project POWER will test the efficacy of a multi-session HIV Prevention program, adapted from an existing program (Project SAFE), for incarcerated women in the rural South.

Interventions

  • BEHAVIORAL Project POWER HIV Risk-reduction Intervention
  • BEHAVIORAL NC DOC Standard of Care for STIs

Trial Details

FieldValue
Enrollment Target 598 participants
Start Date 2009-03
Est. Completion 2012-12
Phase NA

What the finished NCT01111721 record still lists

NCT01111721 is an interventional study that assigns participants to a tested intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 2 interventions - of which Project POWER HIV Risk-reduction Intervention is the first listed.

NCT01111721 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01111721 about?

NCT01111721 is a clinical study titled "Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners". Project POWER will test the efficacy of a multi-session HIV Prevention program, adapted from an existing program (Project SAFE), for incarcerated women in the rural South.

What is the current status of trial NCT01111721?

This trial is currently completed. It is a NA study. The enrollment target is 598 participants. The study started on 2009-03. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01111721?

The interventions under investigation include: Project POWER HIV Risk-reduction Intervention (BEHAVIORAL), NC DOC Standard of Care for STIs (BEHAVIORAL).

Who is sponsoring clinical trial NCT01111721?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01111721's enrollment target sits among peer trials

598 174th of 2000 higher than 1,827 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06875973 · 599 participants · Phase 3

    Pelacarsen Roll-over Extension Program

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01111721, the US trial registry maintained by the National Library of Medicine. NCT01111721 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.